Bridgeway Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $101K | Hold |
|
|||||
|
2025
Q2 | $80.2K | Hold |
|
|||||
|
2025
Q1 | $125K | Sell |
|
|||||
|
2024
Q4 | $215K | Buy |
|
|||||
|
2024
Q3 | $318K | Buy |
|
|||||
|
2024
Q2 | $114K | Hold |
|
|||||
|
2024
Q1 | $136K | Sell |
|
|||||
|
2023
Q4 | $169K | Sell |
|
|||||
|
2023
Q3 | $217K | Buy |
|
|||||
|
2023
Q2 | $245K | Sell |
|
|||||
|
2023
Q1 | $225K | Buy |
|
|||||
|
2022
Q4 | $141K | Buy |
|
|||||
|
2022
Q3 | $287K | Buy |
|
|||||
|
2022
Q2 | $131K | Sell |
|
|||||
|
2022
Q1 | $1.1M | Hold |
|
|||||
|
2021
Q4 | $936K | Sell |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.28M | Buy |
|
|||||
|
2018
Q1 | $929K | Buy |
|
|||||
|
2017
Q4 | $528K | Sell |
|
|||||
|
2017
Q3 | $884K | Buy |
|
|||||
|
2017
Q2 | $406K | Buy |
|
|||||
|
2017
Q1 | $360K | Hold |
|
|||||
|
2016
Q4 | $392K | Hold |
|
|||||
|
2016
Q3 | $551K | Buy |
|